To assess MG-ADL total score changes from baseline to week 26 in patients initiated on eculizumab before or after 2 years of gMG diagnosis in clinical practice.
No takes yet. Share an insight, caveat, or question.
Muppidi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: